Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata

Zacks2024-10-15

For Immediate Release Chicago, IL – October 15, 2024 – Stocks in this week’s article are Grupo Supervielle S.A. SUPV, Emergent BioSolutions Inc. EBS and Innodata Inc. INOD. 3 Stocks Poised for Better ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2475061639?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9AodUNIHy5ynMRHk2f_IzA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/fc7140c171b67cf9ddc1280d1a32cb83","is_english":true,"pubTime":"2024-10-15 21:34","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2475061639","market":"us","top_or_hot":-1,"title":"Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata","media":"Zacks","content":"<div>\n<p>For Immediate Release\nChicago, IL – October 15, 2024 – Stocks in this week’s article are Grupo Supervielle S.A. SUPV, Emergent BioSolutions Inc. EBS and Innodata Inc. INOD.\n3 Stocks Poised for Better ...</p>\n\n<a href=\"https://finance.yahoo.com/news/zacks-com-featured-highlights-grupo-133400852.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-15 21:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/zacks-com-featured-highlights-grupo-133400852.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For Immediate Release\nChicago, IL – October 15, 2024 – Stocks in this week’s article are Grupo Supervielle S.A. SUPV, Emergent BioSolutions Inc. EBS and Innodata Inc. INOD.\n3 Stocks Poised for Better ...</p>\n\n<a href=\"https://finance.yahoo.com/news/zacks-com-featured-highlights-grupo-133400852.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4207","symbol_name":"综合性银行","start_time":0,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-grupo-133400852.html","article_id":"2475061639","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9AodUNIHy5ynMRHk2f_IzA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/fc7140c171b67cf9ddc1280d1a32cb83"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2475061639","pubTimestamp":1728999240,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Chicago, IL – October 15, 2024 – Stocks in this week’s article are Grupo Supervielle S.A. SUPV, Emergent BioSolutions Inc. EBS and Innodata Inc. INOD.3 Stocks Poised for Better Returns with New Analyst Coverage. The initiation of coverage by new analysts can provide substantial advantages to investors and exert a notable impact on financial markets. Analysts typically possess specialized knowledge and expertise in particular industries or sectors. Through thorough research and analysis, they offer investors critical insights into a company's financial health, growth potential, competitive standing, and industry trends — insights that are often difficult for individual investors to acquire independently.Grupo Supervielle S.A., Emergent BioSolutions Inc. and Innodata Inc. are three stocks that have witnessed new analyst coverage lately. These are, therefore, expected to attract investor attention.Coverage initiation on a stock by analyst usually portrays higher investor inclination. Inve","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4207":"综合性银行","BK4139":"生物科技","BK4583":"猴痘概念","INOD":"Innodata Inc","EBS":"Emergent Biosolutions","SUPV":"Grupo Supervielle S.A.","BK4106":"数据处理与外包服务","BK4123":"调查和咨询服务"},"translate_title":"Zacks.com的特色亮点包括Grupo Supervielle、Emergent BioSolutions和Innodata","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBS":1,"INOD":1,"SUPV":0.9},"content_text":"For Immediate Release\nChicago, IL – October 15, 2024 – Stocks in this week’s article are Grupo Supervielle S.A. SUPV, Emergent BioSolutions Inc. EBS and Innodata Inc. INOD.\n3 Stocks Poised for Better Returns with New Analyst Coverage\nThe initiation of coverage by new analysts can provide substantial advantages to investors and exert a notable impact on financial markets. Analysts typically possess specialized knowledge and expertise in particular industries or sectors. Through thorough research and analysis, they offer investors critical insights into a company's financial health, growth potential, competitive standing, and industry trends — insights that are often difficult for individual investors to acquire independently.\nGrupo Supervielle S.A., Emergent BioSolutions Inc. and Innodata Inc. are three stocks that have witnessed new analyst coverage lately. These are, therefore, expected to attract investor attention.\nCoverage initiation on a stock by analyst(s) usually portrays higher investor inclination. Investors, on their part, often assume that there is something special in a stock to attract analysts to cover it. In other words, they believe that the company coming under the microscope definitely holds some value.\nDo analysts create value for companies by initiating coverage? Of course, they do because they play an important intermediary role with their extensive access to relevant data. Many investors have immense faith in analysts' research as they fear that a lack of information might trigger inefficiencies.\nObviously, stocks are not randomly chosen to cover. A new coverage on a stock usually reflects a reassuring future envisioned by the analyst(s). At times, increased investor focus on a stock motivates analysts to take a closer look at it. After all, who doesn't like to produce something that is already in demand? Hence, we often find that analysts' ratings on newly added stocks are more favorable than their ratings on continuously covered stocks.\nNeedless to say, the average change in broker recommendation is preferable to a single recommendation change.\nImpact on Stock Price\nThe price movement of a stock is generally a function of the recommendations from new analysts. Stocks typically see an upward price movement with new analyst coverage compared to what they witness with a rating upgrade under an existing coverage. Positive recommendations — Buy and Strong Buy — generally lead to a significantly positive price reaction compared with Hold recommendations. On the contrary, analysts hardly initiate coverage with a Strong Sell or Sell recommendation.\nNow, if an analyst issues a new recommendation on a company that has very little or no existing coverage, investors start paying more attention to it. Also, any further information attracts portfolio managers to build a position in the stock.\nSo, it's a good strategy to bet on stocks that have seen increased analyst coverage over the last few weeks.\nHere are three out of the five stocks that passed the screen:\nGrupo Supervielle S.A.: This is a Buenos Aires, Argentina-based financial services holding company. SUPV currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.\nSUPV shares have gained 31.3% over the past three months against the industry's 10.3% decline. Earnings per share (EPS) estimates for SPUV have moved north to $1.29 from $1.20 for 2024 in the past 60 days, depicting analysts' optimism over the company's prospects. The estimated figure indicates 59.3% growth from a year ago.\nEmergent BioSolutions: Headquartered in Gaithersburg, MD, this is a life sciences company. EBS currently has a Zacks Rank #2 (Buy).\nEmergent BioSolutions' shares have lost 22.6% over the past three months, underperforming the industry's 1% rise. Yet, the bottom-line estimates for EBS have improved to a loss of $1.30 per share from a loss of $1.98 per share for 2024 in the past 30 days. It also has a favorable VGM Score of B.\nInnodata: Based in Ridgefield Park, NJ, this company operates as a global data engineering company. INOD currently has a Zacks Rank #3 (Hold).\nINOD shares have lost 17.9% over the past three months compared with the industry's 9.6% rise. Nonetheless, EPS estimates for 2024 have moved north to 21 cents from 18 cents in the past 60 days. Innodata also has a favorable VGM Score of B.\nYou can get the remaining stock on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your trading. Further, you can also create your strategies and test them first before taking the investment plunge.\nThe Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.\nClick here to sign up for a free trial of the Research Wizard today.\nFor the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2349685/3-stocks-poised-for-better-returns-with-new-analyst-coverage\nDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.\nAbout Screen of the Week\nZacks.com created the first and best screening system on the web earning the distinction as the \"#1 site for screening stocks\" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.\nStrong Stocks that Should Be in the News\nMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 \"Strong Buys\" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.\nFollow us on Twitter:  https://www.twitter.com/zacksresearch\nJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch\nZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.\nContact: Jim Giaquinto\nCompany: Zacks.com\nPhone: 312-265-9268\nEmail: pr@zacks.com\nVisit: https://www.zacks.com/\nZacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks \"Terms and Conditions of Service\" disclaimer. www.zacks.com/disclaimer.\nPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nEmergent Biosolutions Inc. (EBS) : Free Stock Analysis Report\nInnodata Inc. (INOD) : Free Stock Analysis Report\nGrupo Supervielle S.A. (SUPV) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2475061639"}